# Proteostasis Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/proteostasis-therapeutics

- Industry: Biotechnology
- Headquarters: Boston, US
- Website: www.proteostasis.com
- Total disclosed funding: $82M
- Latest round: Series B (Sep 8, 2015)
- Investors on record: 8

## About

Founded in 2006 and based in Massachusets, US, Proteostasis Therapeutics, Inc. operates as a developer of small molecule therapeutics designed to control the body protein homeostasis, or the Proteostasis Network. The company's products works on the treatment of cystic fibrosis, neurodegenerative diseases, and orphan diseases

## Funding rounds

- Series B, Sep 8, 2015, $37M — HealthCare Ventures, New Enterprise Associates, Novartis Venture Fund, F-Prime Capital, Elan SBI Capital Partners, Sanofi Ventures, Rock Springs Capital, Cormorant Asset Management
- Series A, Aug 25, 2008, $45M — HealthCare Ventures, New Enterprise Associates, Novartis Venture Fund, F-Prime Capital, Sanofi Ventures

## Investors

- HealthCare Ventures — Series A, Series B
- New Enterprise Associates (https://capitalatlas.ai/funds/new-enterprise-associates) — Series A, Series B
- Novartis Venture Fund (https://capitalatlas.ai/funds/novartis-venture-fund) — Series A, Series B
- F-Prime Capital (https://capitalatlas.ai/funds/f-prime-capital) — Series A, Series B
- Sanofi Ventures (https://capitalatlas.ai/funds/sanofi-ventures) — Series A, Series B
- Elan SBI Capital Partners (https://capitalatlas.ai/funds/elan-sbi-capital-partners) — Series B
- Rock Springs Capital — Series B
- Cormorant Asset Management (https://capitalatlas.ai/funds/cormorant-asset-management) — Series B